Cord blood stem cell cryopreservation

Transfusion Medicine and Hemotherapy

Volumn 34, Issue 4, 2007, Pages 276-285

  Woods, Erik J ^a,b,e   Pollok, Karen E ^b   Byers, Michael A ^a   Perry, Brandon C ^a   Purtteman, Jester ^c   Heimfeld, Shelly ^d   Gao, Dayong ^a,c  

^a Indiana Cord Blood Bank   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e General BioTechnology LLC   (United States)

Author keywords

Cryopreservation; Hematopoietic stem cells; Mesenchymal stem cells; Umbilical cord blood

Indexed keywords

CRYOPROTECTIVE AGENT; DEXTRAN; DIMETHYL SULFOXIDE; HETASTARCH;

BLOOD BANK; BLOOD CULTURE; BLOOD STORAGE; CELL SUSPENSION; CELL TYPE; CELL VIABILITY; COOLING; CRYOPRESERVATION; FREEZING; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; MONONUCLEAR CELL; NONHUMAN; REVIEW; STEM CELL; THAWING; UMBILICAL CORD BLOOD;

EID: 34547763196     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104183     Document Type: Review

References (75)

1. Hall PA, Watt FM: Stem cells: the generation and maintenance of cellular diversity. Development 1989;106:619-633.
2. Bruder SP, Jaiswal N, Haynesworth SE: Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997;64:278-294.
3. Korbling M, Estrov Z: Adult stem cells for tissue repair - a new therapeutic concept? N Engl J Med 2003;349:570-582.
4. Horowitz MM: Uses and growth of hematopoietic cell transplantation; in Blume KG, Forman SJ, Appelbaum FR (eds): Thomas' Hematopoietic Cell Transplantation, 3rd ed. Malden, Blackwell, 2004, pp 9-15.
5. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McCullough J, et al: Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993;328:593-602.
6. Adamson JW: Cord blood stem cell banking and transplantation. Stem Cells 1997;15(suppl 1):57-61.
7. Gluckman, E: The therapeutic potential of fetal and neonatal hematopoietic stem cells. N Engl J Med 1996;335:1839-1840.
8. Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, Ciocci G, Carrier C, Stevens CE, Rubinstein P: Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;355:157-166.
9. Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NK, McGlave PB, Sender L, Cairo MS: Successful transplantation of HLA matched and HLA mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft vs. host disease. Blood 1996;88:795-802.
10. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, Berkowitz RL, Cabbad M, Dobrila NL, Taylor PE, Rosenfield RE, Stevens CE: outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565-1577.
11. Sousa T, de Sousa ME, Godinho MI Mendes C, Carvalhais A, Barbosa IL: Umbilical cord blood processing: volume reduction and recovery of CD34+ cells. Bone Marrow Transplant 1997;19:311-313.
12. Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, Esperou H, Thierry D, Socie G, Lehn P, et al: Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989;321:1174-1178.
13. Lee MW, Choi J, Yang MS, Moon YJ, Park JS, Kim HC, Kim YJ: Mesenchymal stem cells from cryopreserved human umbilical cord blood. Biochem Biophys Res Commun 2004;320:273-278.
14. Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW, Gerson SL, Laughlin MJ, Loberiza FR Jr, Moseley AB, Bacigalupo A: Co-transplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005;11:389-398.
15. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O: Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-1441.
16. Horwitz EM, Prockop DJ, Gordon PL, Koo WW, Fitzpatrick LA, Neel MD, McCarville ME, Orchard PJ, Pyeritz RE, Brenner MK: Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 2001;97:1227-1231.
17. Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W: Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy and Hurler syndrome. Bone Marrow Transplant 2002;30:215-222.
18. Chang YJ, Tseng CP, Hsu LF, Hsieh TB, Hwang SM: Characterization of two populations of mesenchymal progenitor cells in umbilical cord blood. Cell Biol Int. 2006;30:495-499.
19. Rubinstein P, Dobrila L, Rosenfeld RE: Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A 1995;92:10119-10122.
20. Skoric D, Balint B, Petakov M, Sindjic M, Rodic P: Collection strategies and cryopreservation of umbilical cord blood. Transfus Med 2007;17:107-113.
21. Sputtek A: Kryokonservierung von Blutzellen und hämatopoetischen Stammzellen; in Müller-Eckhardt C, Kiefel V (Hrsg): Transfusionsmedizin. Berlin, Springer, 2004, pp 133-144.
22. Sputtek A, Gutensohn K, Hummel K, Löliger C, Kühnl P: Zur Kryokonservierung von Blutstammzellen. J Lab Med 1996;20:70-77.
23. Körber C, Scheiwe MW, Boutron P, Rau G: The influence of hydroxyethyl starch on ice formation in aqueous solutions. Cryobiology 1982;19:478-492.
24. Sputtek A, Sputtek R: Cryopreservation in transfusion medicine and hematology; in Fuller BJ, Lane N, Benson EE (eds): Life in the Frozen State. Boca Raton, CRC Press, 2004, pp 483-502.
25. Mazur P: Freezing of living cells: mechanisms and implications. Am J Physiol 1984;247:C125-C142.
26. Gao DY, Liu J, Liu C, McGann LE, Watson PF, Kleinhans FW, Mazur P, Critser ES, Critser JK: Prevention of osmotic injury to human spermatozoa during the addition and removal of glycerol. Hum Reprod 1995;10:1109-1122.
27. Mazur P, Leibo SP, Chu EHY: A two-factor hypothesis of freezing injury. Exp Cell Res 1972;71:345-355.
28. Woods EJ, Liu J, Derrow CW, Smith FO, Williams DA, Critser JK: Osmometric and permeability characteristics of human placental/umbilical cord blood CD34+ cells and their application to cryopreservation. J Hematother Stem Cell Res 2003;9:161-173.
29. Woods EJ, Liu J, Pollok K, Hartwell J, Smith FO, Williams DA, Yoder MC, Critser JK: A theoretically optimized method for cord blood stem cell cryopreservation. J Hematother Stem Cell Res 2003;12:341-350.
30. de Vries EGE, Vellenga E, Kluin-Nelemans JC, Mulder NH: The happy destiny of frozen haematopoietic stem cells: from immature stem cells to mature applications. Eur J Cancer 2004;40:1987-1992.
31. Sputtek A, Jetter S, Hummel K, Kühnl P: Cryopreservation of peripheral blood progenitor cells: characteristics of suitable techniques; in Sibrowski W, Stangel W, Blauhut B (Hrsg): Transfusionmedizin 1995/96. Beitr Infusionsther Transfusionsmed. Basel, Karger, 1997, vol 34, pp 79-83.
32. Donaldson C, Armitage WJ, Denning-Kendall PA, Nicol AJ, Bradley BA, Hows JM: Optimal cryopreservation of human umbilical cord blood. Bone Marrow Transplant 1996;18:725-731.
33. Hunt CJ, Armitage SE, Pegg DE: Cryopreservation of cord blood: 1. Osmotically inactive volume, hydraulic conductivity and permeability of CD34+ cells to dimethyl sulphoxide. Cryobiology 2003;46:61-75.
34. Hunt CJ, Armitage SE, Pegg DE: Cryopreservation of cord blood: 2. Tolerance of CD34+ cells to multimolar dimethyl sulphoxide and the effect of cooling rate on recovery after freezing and thawing. Cryobiology 2003;46:76-87.
35. Meyer TPH, Hofmann B, Zaisserer J, Jacobs VR, Fuchs B, Rapp S, Weinauer F, Burkhart J: Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood. Cytotherapy 2006;8:265-276.
36. Douay L, Gorin NC, David R, Stachowiak J, Salmon C, Najman A, Duhamel G: Study of granulocyte-macrophage progenitor (CFUc) preservation after slow freezing of bone marrow in the gas phase of liquid nitrogen. Exp Hematol 1982;10:360-366.
37. Rowley SD, Anderson GL: Effects of DMSO exposure without cryopreservation of hematopoietic progenitor cells. Bone Marrow Transplant 1993;11:389-393.
38. Branch DR, Calderwood S, Cecutti MA, Herst R, Solh H: Hematopoietic progenitor cells are resistant to dimethyl sulfoxide toxicity. Transfusion 1994;34:887-890.
39. Liu J, Zieger MAJ, Lakey JRT, Woods EJ, Critser JK: The determination of membrane permeability coefficients of canine pancreatic islet cells and their application to islet cryopreservation. Cryobiology 1997;35:1-13.
40. Mazur P: Equilibrium, quasi-equilibrium and nonequilibrium freezing of mammalian embryos. Cell Biophys 1990;17:53-92.
41. Choi CW, Kim BS, Seo JH, Shin SW, Kim YH, Kim JS: Long-term engraftment stability of peripheral blood stem cells cryopreserved using the dumpfreezing method in a -80 °C mechanical freezer with 10% dimethyl sulfoxide. Int J Hematol 2001;72:245-250.
42. Muramaki M, Hara I, Miyake H, Yamada Y, Okada H, Kamidono S: Long-term cryopreservation of peripheral blood stem cells in patients with advanced germ cell tumors using the dump-freezing method at -80 °C. Oncol Rep 2003;10:1993-1998.
43. Morris GJ, Acton E, Faszer K, Franklin A, Yin H, Bodine R, Pareja J, Zaninovic N, Gosden R: Cryopreservation of murine embryos, human spermatozoa and embryonic stem cells using a liquid nitrogen-free, controlled rate freezer. Reprod Biomed Online 2006 13:421-426.
44. Purtteman J: Development of a controlled rate cooling instrument for cryopreservation of hematopoietic stem cells. Thesis, University of Washington, Department of Mechanical Engineering, 2006.
45. Meryman HT: Osmotic stress as a mechanism of freezing injury. Cryobiology 1971;8:489-500.
46. Steponkus PL, Wolfe J, Dowgert JF: Stresses induced by contraction and expansion during a freeze-thaw cycle: a membrane perspective; in Morris GJ, Clarke A (eds): Effects of Low Temperatures on Biological Membranes. New York, Academic Press, 1981, pp 307-322.
47. Ding W, Yu J, Woods E, Heimfeld S, Gao D: Simulation of removing permeable cryoprotective agents from cryopreserved blood with hollow fiber modules. J Membr Sci 2007;288:85-93.
48. Srour EF, Tong X, Sung KW, Plett PA, Rice S, Daggy J, Yiannoutsos CT, Abonour R, Orschell CM: Modulation of in vitro proliferation kinetics and primitive hematopoietic potential of individual human CD34+CD38-/lo cells in G0. Blood 2005;105:3109-116.
49. Theimann FT, Moore KA, Smogorzewska EM, Lemischka IR, Crooks GM: The murine stromal cell line AFT024 acts specifically on human CD34+CD38- progenitors to maintain primitive function and immunophenotype in vitro. Exp Hematol 1998;26:612-619.
50. Yang H, Acker JP, Hannon J, Miszta-Lane H, Akabutu JJ, McGann LE: Damage and protection of UC blood cells during cryopreservation. Cytotherapy 2001;3:377-386.
51. Abrahamsen JF, Rusten L, Bakken AM, Bruserud O: Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide. Transfusion 2004;44:785-789.
52. Rocha V, Wagner JE Jr, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E: Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Eng. J Med 2000;342:1846-54.
53. Brunstein CG, Wagner JE: Cord blood transplantation for adults. Vox Sang 2006;91:195-205.
54. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM: Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004;351:2265-2275.
55. Barker JN, Weisdorf DJ, Wagner JE: Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med 2001;344:1870-1871.
56. Kai S, Misawa M, Iseki T, et al: Double-unit cord blood transplantation in Japan. Blood 2004;104:5166a (abstract).
57. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS, Verfaillie CM, Wagner JE: Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005;105:1343-1347.
58. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, Jacobsen N, Ruutu T, de Lima M, Finke J, Frassoni F, Gluckman E: Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004;351:2276-2285.
59. Orkin SH, Zon LI: Hematopoiesis and stem cells: plasticity versus developmental heterogeneity. Nat Immunol 2002;3:323-328.
60. Goodwin HS, Bicknese AR, Chien SN, Bogucki BD, Quinn CO, Wall DA: Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol Blood Marrow Transplant 2001;7:581-588.
61. Deans RJ, Moseley AB: Mesenchymal stem cells: biology and potential clinical uses. Exp. Hematol 2000;28:875-884.
62. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-49.
63. Romanov YA, Svintsitskaya VA, Smirnov VN: Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSClike cells from umbilical cord. Stem Cells 2003;21:105-110.
64. Verfaillie CM: Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. Blood 1993;82:2045-2053.
65. Clausen J, Stockschlader M, Fehse N, Hassan HT, Gabl C, Zander AR: Blood-derived macrophage layers in the presence of hydrocortisone support myeloid progenitors in long-term cultures of CD34+ cord blood and bone marrow cells. Ann Hematol 2000;79:59-65.
66. Verfaillie CM: Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term in vitro hematopoiesis. Blood 1992;79:2821-2826.
67. Shimakura Y, Kawada H, Ando K, Sato T, Nakamura Y, Tsuji T, Kato S, Hotta T: Murine stromal cell line HESS-5 maintains reconstituting ability of ex vivo-generated hematopoietic stem cells from human bone marrow and cytokine-mobilized peripheral blood. Stem Cells 2000;18:183-189.
68. Kusadasi N, Koevoet JL, van Soest PL Ploemacher RE: Stromal support augments extended long-term ex vivo expansion of hemopoietic progenitor cells. Leukemia 2001;15:1347-1358.
69. Gough NM, Williams RL, Hilton DJ, Pease S, Willson TA, Stahl J, Gearing DP, Nicola NA, Metcalf D: LIF: a molecule with divergent actions on myeloid leukaemic cells and embryonic stem cells. Reprod Fertil Dev 1989;1:281-288.
70. Murray P, Edgar D: The regulation of embryonic stem cell differentiation by leukaemia inhibitory factor (LIF). Differentiation 2001;86:227-234.
71. Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL: Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998;176:57-66.
72. Majumdar MK, Thiede MA, Haynesworth SE, Bruder SP, Gerson SL: Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 2000;9:841-848.
73. Kadereit S, Deeds LS, Haynesworth SE, Koc ON, Kozik MM, Szekely E, Daum-Woods K, Goetchius GW, Fu P, Welniak LA, Murphy WJ, Laughlin MJ: Expansion of LTC-ICs and maintenance of p21 and BCL-2 Expression in cord blood CD34+/CD38-early progenitors cultured over human MSCs as a feeder layer. Stem Cells 2002;20:573-582.
74. Kim DW, Chung YJ, Kim TG, Kim YL, Oh IH: Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood 2004;103:1941-1948.
75. Frassoni F, Labopin M, Bacigalupo A: Expanded mesenchymal stem cells, co-infused with HLA-identical hematopoietic stem cell transplant, reduce acute and chronic graft versus host disease: a matched-pair analysis. Bone Marrow Transplant 2002;29(suppl 2):75.